Updated
Gilead SciencesGILD · Healthcare
$169.30+1.46%
Market cap$210.1B
IndustryDrug Manufacturers - General
Gilead Sciences (GILD) Superinvestor holders
34 of the superinvestors we track hold Gilead Sciences (GILD) in their latest 13F filings, $6.6B in total.
Summary
The largest holder is Dodge & Cox, with $3.0B, 1.6% of the portfolio.
In their latest quarter: 1 opened a new position, 17 added, 13 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Dodge & Cox | Trimmed | 23,677,567 | $3.0B | 1.6% | Q2 2026 |
| Mark Donovan Boston Partners |
Added | 6,017,958 | $762M | 0.7% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Added | 3,216,892 | $406M | 0.9% | Q2 2026 |
| Josef Lakonishok LSV Asset Management |
Trimmed | 2,371,061 | $353M | 0.7% | Q3 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 2,294,789 | $290M | 0.2% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Added | 2,217,376 | $280M | 0.4% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 1,940,617 | $245M | 0.4% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 1,532,634 | $228M | 0.3% | Q3 2026 |
| Steve Cohen Point72 Asset Management |
Added | 1,437,685 | $182M | 0.3% | Q2 2026 |
| Man Group Man Group plc |
Added | 1,235,196 | $156M | 0.3% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Trimmed | 1,088,957 | $138M | 0.1% | Q2 2026 |
| Arrowstreet Capital | New position | 959,904 | $121M | 0.1% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Trimmed | 695,432 | $87M | 0.0% | Q2 2026 |
| David Vogel Voloridge Investment Management |
Added | 559,829 | $71M | 0.3% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 409,174 | $52M | 0.0% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Added | 381,851 | $48M | 0.1% | Q2 2026 |
| Ken Fisher Fisher Investments |
Added | 305,850 | $46M | 0.0% | Q3 2026 |
| Ray Dalio Bridgewater Associates |
Added | 290,881 | $37M | 0.2% | Q2 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 204,677 | $26M | 0.0% | Q2 2026 |
| John Rogers Ariel Investments |
Trimmed | 195,657 | $25M | 0.2% | Q2 2026 |
| Alan Howard Brevan Howard |
Added | 123,329 | $16M | 0.2% | Q2 2026 |
| Fred DiSanto Ancora Holdings |
Trimmed | 121,465 | $15M | 0.3% | Q2 2026 |
| Neil Hennessy Hennessy Advisors |
Trimmed | 66,800 | $10M | 0.4% | Q3 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Added | 74,896 | $9M | 0.0% | Q2 2026 |
| First Manhattan First Manhattan Co |
Trimmed | 70,366 | $9M | 0.0% | Q2 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Added | 46,442 | $6M | 0.0% | Q2 2026 |
| Chuck Royce Royce Investment Partners |
Held | 29,000 | $4M | 0.0% | Q3 2026 |
| Alger Fred Alger Management |
Trimmed | 27,956 | $4M | 0.0% | Q2 2026 |
| Alan Breed Edgewood Management |
Held | 27,837 | $4M | 0.0% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
Trimmed | 18,000 | $2M | 0.0% | Q2 2026 |
| Jeremy Grantham GMO |
Trimmed | 15,811 | $2M | 0.0% | Q2 2026 |
| Alec Litowitz Magnetar Capital |
Added | 13,412 | $2M | 0.0% | Q2 2026 |
| Eric Marshall Hodges Capital Management |
Added | 9,315 | $1M | 0.1% | Q2 2026 |
| Mairs & Power Mairs & Power Inc |
Held | 2,275 | $287,424 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 35 |
| Q1 2026 | 35 |
| Q4 2025 | 31 |
| Q3 2025 | 32 |
| Q2 2025 | 33 |
| Q1 2025 | 34 |
| Q4 2024 | 33 |
| Q3 2024 | 30 |
Questions about Gilead Sciences
Which superinvestors own Gilead Sciences?
34 of the superinvestors we track hold Gilead Sciences (GILD) in their latest 13F filings, $6.6B in total. Dodge & Cox, Mark Donovan, Brandon Haley, Josef Lakonishok, David Shaw, Jim Simons.
Who is the largest superinvestor holder of GILD?
The largest holder is Dodge & Cox, with $3.0B, 1.6% of the portfolio.
From Gilead Sciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.